These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23161211)

  • 1. Capillary electromigration based techniques in diagnostics of prion protein caused diseases.
    Sobrova P; Ryvolova M; Adam V; Kizek R
    Electrophoresis; 2012 Dec; 33(24):3644-52. PubMed ID: 23161211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future molecular diagnostics for prion diseases.
    Lehto MT; Peery HE; Cashman NR
    Expert Rev Mol Diagn; 2006 Jul; 6(4):597-611. PubMed ID: 16824033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of prion diseases: creating clarity or causing confusion?
    Rubenstein R
    Electrophoresis; 2012 Dec; 33(24):3631-43. PubMed ID: 23161058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy.
    Schmerr MJ; Jenny AL; Bulgin MS; Miller JM; Hamir AN; Cutlip RC; Goodwin KR
    J Chromatogr A; 1999 Aug; 853(1-2):207-14. PubMed ID: 10486728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of prion protein using a capillary electrophoresis-based competitive immunoassay with laser-induced fluorescence detection and cyclodextrin-aided separation.
    Yang WC; Yeung ES; Schmerr MJ
    Electrophoresis; 2005 May; 26(9):1751-9. PubMed ID: 15815999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comments on present-day spread and epidemiology of BSE and prion diseases].
    Bodemer W; Kaup FJ
    Gesundheitswesen; 2004 Feb; 66 Suppl 1():S21-5. PubMed ID: 14770333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies.
    Beekes M; McBride PA
    FEBS J; 2007 Feb; 274(3):588-605. PubMed ID: 17288548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human spongiform encephalopathies. Diseases caused by prions].
    Jørn N; Hansen D; Hansen NJ
    Ugeskr Laeger; 1996 Jul; 158(28):4066-72. PubMed ID: 8701521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro bioassay systems for the amplification and detection of abnormal prion PrP(Sc) in blood and tissues.
    Zhang W; Wu J; Li Y; Carke RC; Wong T
    Transfus Med Rev; 2008 Jul; 22(3):234-42. PubMed ID: 18572098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice.
    Safar JG; Scott M; Monaghan J; Deering C; Didorenko S; Vergara J; Ball H; Legname G; Leclerc E; Solforosi L; Serban H; Groth D; Burton DR; Prusiner SB; Williamson RA
    Nat Biotechnol; 2002 Nov; 20(11):1147-50. PubMed ID: 12389035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple and specific detection of abnormal prion protein by a magnetic bead-based immunoassay coupled with laser-induced fluorescence spectrofluorometry.
    Kim JI; Wang C; Kuizon S; Xu J; Barengolts D; Gray PC; Rubenstein R
    J Neuroimmunol; 2005 Jan; 158(1-2):112-9. PubMed ID: 15589044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All major prion types recognised by a multiplex immunofluorometric assay for disease screening and confirmation in sheep.
    Tang Y; Gielbert A; Jacobs JG; Baron T; Andreoletti O; Yokoyama T; Langeveld JP; Sauer MJ
    J Immunol Methods; 2012 Jun; 380(1-2):30-9. PubMed ID: 22498749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in prion disease research: diagnostic tools and in vitro cell culture models.
    Sakudo A; Nakamura I; Ikuta K; Onodera T
    J Vet Med Sci; 2007 Apr; 69(4):329-37. PubMed ID: 17485919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanidine hydrochloride extraction and detection of prion proteins in mouse and hamster prion diseases by ELISA.
    Kang SC; Li R; Wang C; Pan T; Liu T; Rubenstein R; Barnard G; Wong BS; Sy MS
    J Pathol; 2003 Apr; 199(4):534-41. PubMed ID: 12635145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies.
    Priola SA; Vorberg I
    Methods Mol Biol; 2004; 268():517-40. PubMed ID: 15156065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics applications in prion biology and structure.
    Moore RA; Faris R; Priola SA
    Expert Rev Proteomics; 2015 Apr; 12(2):171-84. PubMed ID: 25795148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical prion diseases in humans and animals.
    Tranulis MA; Benestad SL; Baron T; Kretzschmar H
    Top Curr Chem; 2011; 305():23-50. PubMed ID: 21598097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.